Hiring Trend Watchpoints
High-performing operators in Point-of-Care & Rapid Diagnostics are focusing hiring efforts on several key areas. We expect to see increased demand for specialized sales and commercial excellence roles, particularly those targeting high-growth platforms like advanced patient monitoring, urgent care, and specific disease areas (e.g., GLP-1 related diagnostics). Companies are making incremental investments in sales force expansion and reallocation to capture market share. A significant trend is the recruitment of AI/ML engineers, data scientists, automation specialists, and computational biologists, as firms integrate AI across their value chains, from supply chain optimization and G&A functions to assay development and 'autonomous science' initiatives. R&D talent for new diagnostic platforms (molecular, immunoassay, connected care) remains crucial. Additionally, operational excellence roles (lean manufacturing, supply chain analysts) are in demand to drive productivity and cost reduction, alongside M&A integration specialists for strategic acquisitions. Confirmation of theme execution would be indicated by sustained growth in job postings for these specialized roles, new R&D center announcements, and successful integration of acquired talent. Deterioration would be signaled by hiring freezes or significant layoffs in core diagnostics R&D or sales, or a noticeable shift away from digital/AI transformation roles.
Forum Watchlist
Reddit — r/medlabprofessionalsHigh
Discussions on new diagnostic technologies, workflow challenges, point-of-care accuracy, regulatory changes, and instrument performance.
Reddit — r/healthcareMedium
Broader discussions on healthcare trends, policy impacts on diagnostics, and the adoption of decentralized testing models.
Industry Forum — MedWrench.comHigh
Technical discussions, troubleshooting, and reviews of diagnostic instruments, rapid testing devices, and connectivity solutions.
LinkedIn Group — Point-of-Care TestingHigh
Professional discussions on industry news, product launches, clinical applications, regulatory updates, and market dynamics.
Patient Forum — Diabetes DailyMedium
Patient perspectives on the ease of use, accessibility, and impact of rapid/POC tests for chronic disease management (e.g., glucose, HbA1c, ketones).
Industry Publications
- MedTech Dive (medtechdive.com) — Provides comprehensive coverage of the medical device industry, including diagnostics, regulatory changes, market trends, and company-specific news relevant to point-of-care.
- Fierce MedTech (fiercemedtech.com) — Offers in-depth reporting on medical technology, product development, clinical trials, and business strategies, with frequent coverage of diagnostic innovations.
- Diagnostics World News (diagnosticsworldnews.com) — A dedicated publication for the diagnostics industry, covering new tests, technologies, market analysis, and company news specifically for this sector.
- Clinical Lab Products (CLP) (clpmag.com) — Focuses on clinical laboratory management, instrumentation, and diagnostics, including significant coverage of point-of-care solutions and their integration.
- MPO (Medical Product Outsourcing) (mpo-mag.com) — Covers the business of medical device manufacturing, including diagnostics, supply chain, and innovation, offering insights into the production side of the industry.
Second Order Trends
Several second-order trends are emerging within the Diagnostics '26: Point-of-Care & Rapid Diagnostics theme. First, **AI-Driven Diagnostics and 'Autonomous Science'** is gaining traction, with AI and machine learning moving beyond data analysis to influence assay development, computational pathology, personalized treatment pathways, and the development of self-optimizing 'autonomous science' labs. This could lead to entirely new diagnostic modalities and business models. Second, **Decentralization Beyond Infectious Disease** is expanding significantly into chronic disease management (e.g., diabetes, cardiac, oncology markers) and acute care settings, driven by strategic acquisitions and product launches. This broadens the market for rapid, accessible testing beyond its pandemic-driven surge. Third, the **GLP-1 Therapy Support Ecosystem** is developing, as the widespread adoption of GLP-1 drugs for obesity and diabetes creates a secondary demand for diagnostics related to metabolic health, cardiac markers, and monitoring treatment efficacy/side effects, driving POC demand for managing these conditions. Fourth, **Supply Chain Resilience and Reshoring** are becoming critical, with geopolitical factors driving a focus on robust supply chains and potential 'reshoring' of bioprocessing and diagnostic manufacturing, leading to increased domestic investment. Finally, the emphasis on **Connected Care Ecosystems** suggests that rapid diagnostics will increasingly integrate into broader digital health platforms, enabling remote monitoring, data analytics, and seamless information flow between patients, providers, and labs.
Search Keywords Brand Product
- point-of-care test
- rapid diagnostic
- decentralized diagnostic
- immunoassay
- molecular diagnostic
- lateral flow test
- handheld analyzer
- Sofia test
- QuickVue
- Triage cardiac
- ichroma
- AFIAS
- STANDARD F
- STANDARD M
- i-STAT
- ID NOW
- BinaxNOW
- Piccolo chemistry
- Cholestech
- FebriDx
- epoc blood gas
- RAPIDPoint
- Atellica VTLi
- GeneXpert
- cobas liat
- cobas b 101
- cobas pulse
- CoaguChek
- OraQuick HIV
- Veritor Plus
Search Keywords Policy Regulatory
- FDA rapid test approval
- CLIA-waived tests
- Medicare reimbursement diagnostics
- point-of-care regulation
- decentralized testing policy
- China healthcare pricing reform diagnostics
- IVDR regulation
Search Keywords Event Phrases
- JP Morgan Healthcare Conference
- AACC Clinical Lab Expo
- MedTech Conference
- AdvaMed Conference
- BIO International
Google Trend Product Category Intent
• at home rapid test
• point of care testing near me
• urgent care rapid test
• pharmacy diagnostic test
• portable diagnostic device
• home health monitoring kit
Google Trend Consumer Intent
• quick diagnosis for flu
• fast strep test
• blood sugar home test
• cardiac marker test at home
• HIV rapid test kit
Google Trend Macro Policy Terms
• telehealth diagnostic services
• decentralized healthcare access
• FDA home test guidelines
• community health testing programs
Economic Data Watch
1. U.S. Bureau of Economic Analysis (BEA) / Centers for Medicare & Medicaid Services (CMS) — National Health Expenditure Accounts (NHEA)
Not in registryaccess=api
Metric/field National Health Expenditure: Outpatient Care Spending (Annual, Billions USD)
Cadence annual
Why it matters Direct measure of spending in settings where POC diagnostics are heavily utilized, indicating overall demand and market activity.
Signal to watch Increasing spending suggests higher utilization and demand for POC tests.
Confidence: high
2. U.S. Census Bureau — Monthly Retail Trade Survey
Not in registryaccess=api
Metric/field Retail Sales: Health and Personal Care Stores (NAICS 446), Monthly, Billions USD, Seasonally Adjusted
Cadence monthly
Why it matters Reflects consumer spending at pharmacies and drug stores, which are increasingly sites for rapid diagnostics and over-the-counter tests.
Signal to watch Rising sales indicate stronger consumer engagement with health-related retail, including POC test access.
Confidence: high
3. U.S. Bureau of Labor Statistics (BLS) — Producer Price Index (PPI) by Industry
Not in registryaccess=api
Metric/field PPI by Industry: Medical and Diagnostic Laboratories (NAICS 6215), Index (base 1982=100)
Cadence monthly
Why it matters Measures the average change over time in the selling prices received by domestic producers for their output, indicating pricing power and cost pressures for diagnostic service providers.
Signal to watch Increasing PPI suggests diagnostic providers can pass on costs or have stronger demand, impacting profitability.
Confidence: high
4. U.S. Bureau of Labor Statistics (BLS) — Current Employment Statistics (CES)
Matched (medium)lab_headcount · access=api
Metric/field Total Nonfarm Payrolls: Health Care and Social Assistance (NAICS 62), Thousands of Persons, Seasonally Adjusted
Cadence monthly
Why it matters Growth in healthcare employment, particularly in outpatient and ambulatory settings, signifies increased capacity for patient visits and diagnostic testing.
Signal to watch Consistent growth in healthcare employment indicates expanding service capacity and potential for higher test volumes.
Confidence: high
5. Federal Reserve (FRED) — Federal Funds Rate
Not in registryaccess=api
Metric/field Effective Federal Funds Rate (DFF), Percent
Cadence daily
Why it matters Influences borrowing costs for healthcare providers investing in new equipment and for companies pursuing M&A, impacting growth and expansion.
Signal to watch Lower rates can encourage capital expenditure and M&A, potentially boosting adoption of new POC technologies.
Confidence: high
Free Alt Data Watch
1. Google Trends — Search Interest Data
Not in registry
Metric/field Search interest for 'urgent care near me' (United States, Past 90 days, Relative Search Volume)
Cadence daily
Why it matters Provides a real-time proxy for consumer demand for immediate, decentralized healthcare services where POC diagnostics are frequently performed.
Signal to watch Sustained or increasing search interest indicates strong underlying demand for accessible, rapid care.
Confidence: medium
2. Centers for Disease Control and Prevention (CDC) — FluView: Weekly U.S. Influenza Surveillance Report
Not in registry
Metric/field Percentage of outpatient visits for influenza-like illness (ILI) reported by the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet)
Cadence weekly
Why it matters Directly correlates with demand for rapid infectious disease tests (e.g., flu, strep, COVID-19), a significant component of POC diagnostics.
Signal to watch Rising ILI percentages suggest increased demand for rapid respiratory pathogen testing.
Confidence: high
3. ClinicalTrials.gov — Clinical Study Database
Not in registry
Metric/field Number of new studies registered with keywords 'point-of-care diagnostics' OR 'rapid diagnostics' (filtered by study start date)
Cadence monthly
Why it matters Tracks the innovation pipeline and R&D investment in the POC diagnostics space, signaling future product launches and market expansion.
Signal to watch Increasing number of new trials indicates a robust and growing innovation landscape for POC.
Confidence: medium
4. U.S. Food and Drug Administration (FDA) — 510(k) Clearances and PMA Approvals Database
Not in registry
Metric/field Number of new diagnostic devices cleared/approved (filtered by 'point-of-care' or 'rapid' in device name/description)
Cadence monthly
Why it matters Direct indicator of new diagnostic products entering the market, including POC devices, which can drive revenue for theme members.
Signal to watch A steady or increasing rate of clearances/approvals suggests a healthy pipeline and market expansion.
Confidence: high
5. Google News / Industry News Aggregators (e.g., MedTech Dive) — News Article Mentions
Not in registry
Metric/field Frequency of articles mentioning 'point-of-care diagnostics innovation' OR 'rapid test advancements' OR 'decentralized testing trends'
Cadence daily
Why it matters Provides qualitative insights into industry trends, new product announcements, competitive landscape, and regulatory developments.
Signal to watch Increased positive mentions indicate a dynamic and growing market with new opportunities and technological progress.
Confidence: medium
Paid Alt Data Watch
1. IQVIA — National Sales Perspectives (NSP) / Xponent
Matched (medium)iqvia_pharma_sales_channel_data · access=file · map_only
Metric/field U.S. Retail & Non-Retail Sales Volume and Value for 'Rapid Influenza Diagnostic Tests' (RIDTs) and 'Rapid Strep A Tests'
Cadence irregular
Why it matters Provides granular, real-time sales performance and market share data for key rapid diagnostic products, directly impacting theme members' revenues.
Signal to watch Increasing sales volume/value for specific rapid tests indicates strong market demand and adoption.
Confidence: high
2. Earnest Analytics — Transaction Data
Matched (medium)earnest_analytics_credit_debit_card_consumer_spend · access=file · map_only
Metric/field Consumer spending (total dollar amount) at 'Urgent Care Centers' (NAICS 621493) and 'Drug Stores & Pharmacies' (NAICS 446110)
Cadence irregular
Why it matters Reflects actual consumer spending patterns at points of care where rapid diagnostics are performed, indicating demand and patient flow.
Signal to watch Consistent growth in spending at these locations suggests robust patient activity and potential for increased diagnostic testing.
Confidence: high
3. Thinknum Alternative Data — Job Posting Data
Not in registryaccess=file
Metric/field Number of job postings for 'point-of-care specialist' OR 'diagnostic sales representative' OR 'medical device R&D' at key theme companies (e.g., QDEL, ABT, DHR)
Cadence weekly
Why it matters Indicates company-specific and industry-wide investment in growth, R&D, and commercial expansion within the POC diagnostics sector.
Signal to watch Rising job postings suggest companies are expanding operations, investing in new products, or increasing sales efforts.
Confidence: high
4. GlobalData / EvaluateMedTech — Medical Device Market Forecasts
Not in registry
Metric/field Point-of-Care Diagnostics Market Size (USD Billion) and Compound Annual Growth Rate (CAGR) by Segment (e.g., Infectious Disease, Diabetes, Cardiac)
Cadence quarterly
Why it matters Provides forward-looking market growth projections and competitive intelligence, crucial for assessing the long-term potential of the theme.
Signal to watch Upward revisions to market size forecasts or high CAGRs indicate strong growth prospects for the sector.
Confidence: high
5. AlphaSense / Expert Call Transcripts — Expert Call Transcripts
Matched (medium)alphasense_expert_interview_content · access=file · map_only
Metric/field Frequency and sentiment of discussions in expert calls regarding 'point-of-care adoption rates,' 'decentralized testing reimbursement,' OR 'competitive landscape in rapid diagnostics'
Cadence irregular
Why it matters Offers qualitative, forward-looking insights from industry insiders on market dynamics, competitive landscape, and regulatory changes impacting POC diagnostics.
Signal to watch Increased positive sentiment or frequent discussion of favorable trends (e.g., expanding reimbursement) suggests a bullish outlook.
Confidence: high
